<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260803070511N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-09</date_registration>
      <primary_sponsor>Deputy of Research and Technology, Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Ultrasound-Guided Versus Anatomical Landmark-Guided Percutaneous Dilatational Tracheostomy</public_title>
      <acronym>CEULPDT</acronym>
      <scientific_title>Comparison of the Effectiveness of Ultrasound-Guided Versus Anatomical Landmark-Guided Percutaneous Dilatational Tracheostomy in Intensive Care Unit Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2027-09-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/92204</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: The main objective of this study was to compare the effectiveness and safety of ultrasound-guided percutaneous dilatational tracheostomy with the conventional landmark-based technique in ICU patients, Randomization description: After assessment of the eligibility criteria and obtaining informed consent, eligible patients were randomly assigned in a 1:1 ratio to one of the two study groups: the intervention group, in which percutaneous dilatational tracheostomy was performed under ultrasound guidance, and the control group, in which the procedure was performed using the standard anatomical landmark-based technique.

The unit of randomization was the individual patient, and no cluster randomization was applied. To maintain balance between the two groups, block randomization was used. The random allocation sequence was generated before patient enrollment using statistical software. No stratified randomization was performed; therefore, patients were not stratified according to variables such as age, sex, or disease severity.

To ensure allocation concealment, the randomization sequence was placed in sequentially numbered, opaque, sealed envelopes. After confirming patient eligibility and obtaining informed consent, the next envelope in sequence was opened, and the assigned study group was revealed. This process prevented prediction of group assignment before final enrollment.</study_design>
      <phase>3</phase>
      <hc_freetext>Percutaneous dilatational tracheostomy Ultrasound-guided tracheostomy Anatomical landmark-based tracheostomy Prolonged mechanical ventilationTracheostomy-related complications.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients underwent ultrasound-guided PDT, in which bedside ultrasound was used to identify tracheal rings, determine the optimal puncture site, measure skin-to-trachea distance, and avoid vascular or thyroid injury. Needle puncture was performed under static or real-time ultrasound guidance, followed by guidewire insertion. Intervention 2: Control group: Control group: Patients underwent conventional landmark-guided PDT based on palpation of anatomical landmarks without ultrasound assistance.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information related to the primary outcome or similar data, can be shared.

When:
from 2026

To whom:
Only for researchers affiliated with academic institutions.

Conditions:
Only for researchers affiliated with academic institutions.

Where to obtain:
Jamshidi_saeed@yahoo.com

How to obtain:
Via the provided email address.

Comments:
None</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>DR Saeed Jamshidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>no 11 honarestan 25</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9178746936</zip>
        <telephone>+98 51 3868 2039</telephone>
        <email>Jamshidi_saeed@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Saeed Jamshidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>no 11 honarestan 25</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9178746936</zip>
        <telephone>+98 51 3868 2039</telephone>
        <email>jamshidi_saeed@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>•	Critically ill patients requiring tracheostomy due to prolonged mechanical ventilation, airway obstruction, or other medical indications.
•	Age ≥18 years.
•	Patients with stable vital signs and acceptable laboratory values (e.g., normal platelet count, no active infection at the insertion site).
•	Patients who are expected to remain in the hospital for a minimum of 48 hours after the procedure.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with coagulopathies (e.g., anticoagulation therapy that cannot be stopped before the procedure).•
Patients with anatomical deformities of the neck (e.g., extensive scarring from prior surgeries, tumors, or trauma) that preclude either technique.•
Pregnant women or patients who are unable to provide informed consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z93.0 J95.</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Z93.0 — Tracheostomy status Z99.1 — Dependence on respirator    J96.0 — Acute respiratory failure  J95.0 — Tracheostomy complications</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients underwent ultrasound-guided PDT, in which bedside ultrasound was used to identify tracheal rings, determine the optimal puncture site, measure skin-to-trachea distance, and avoid vascular or thyroid injury. Needle puncture was performed under static or real-time ultrasound guidance, followed by guidewire insertion.</i_keyword>
      <i_keyword>Control group: Control group: Patients underwent conventional landmark-guided PDT based on palpation of anatomical landmarks without ultrasound assistance.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>First Sucess rate. Timepoint: The procedure duration was measured in minutes, from the initiation of needle puncture until the appearance of the ventilator waveform (i.e., confirmation of effective ventilation. Method of measurement: Overall success was defined as successful completion of the tracheostomy procedure with correct placement of the tracheostomy tube in the appropriate position.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Procedure time. Timepoint: The procedure duration was measured in minutes, from the initiation of needle puncture until the appearance of the ventilator waveform (i.e., confirmation of effective ventilation). Method of measurement: confirmation of effective ventilation.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Deputy of Research and Technology, Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-03</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>No 11 Honarestan 25 Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
